CPT® Code 90653

1. Indications

The inactivated influenza vaccine (IIV), as represented by CPT® Code 90653, is indicated for the prevention of influenza virus infection. It is particularly recommended for individuals who are at higher risk of developing complications from influenza, including but not limited to:

• High-Risk Populations: Individuals with chronic health conditions, such as asthma, diabetes, or heart disease, who may experience severe illness if infected with the influenza virus.
• Older Adults: Individuals aged 65 years and older, who are more susceptible to severe influenza-related complications.
• Healthcare Workers: Those who work in healthcare settings and may be exposed to influenza viruses, thereby protecting both themselves and their patients.
• Pregnant Women: Pregnant individuals, as they are at increased risk for severe illness from influenza and can also pass antibodies to their infants.

2. Procedure

The administration of the inactivated influenza vaccine (IIV) involves several key procedural steps to ensure safety and efficacy:

• Step 1: Preparation of the Vaccine The vaccine is prepared by ensuring that it is stored at the appropriate temperature and is not expired. The vial is inspected for any particulate matter or discoloration before use.
• Step 2: Patient Assessment Prior to administration, the healthcare provider assesses the patient’s medical history, including any allergies, previous reactions to vaccines, and current health status to determine eligibility for vaccination.
• Step 3: Site Selection and Cleaning The healthcare provider selects an appropriate site for intramuscular injection, typically the deltoid muscle of the upper arm. The site is then cleaned with an antiseptic wipe to reduce the risk of infection.
• Step 4: Administration of the Vaccine The vaccine is drawn into a sterile syringe, and the needle is inserted into the muscle at a 90-degree angle. The vaccine is then injected slowly and steadily.
• Step 5: Post-Administration Care After the injection, the healthcare provider observes the patient for a brief period to monitor for any immediate adverse reactions. The patient is provided with information regarding potential side effects and the importance of follow-up vaccinations if applicable.

3. Post-Procedure

Post-procedure care for the inactivated influenza vaccine (IIV) includes monitoring the patient for any immediate adverse reactions, such as allergic responses or injection site reactions. Patients are typically advised to rest and can resume normal activities unless otherwise directed. Common side effects may include soreness at the injection site, mild fever, or fatigue, which usually resolve within a few days. It is important for patients to be informed about the signs of more serious reactions and to seek medical attention if they experience difficulty breathing, swelling of the face or throat, or a rapid heartbeat. Additionally, patients should be encouraged to keep track of their vaccination history for future reference and to ensure they receive the vaccine annually, as influenza viruses can change from year to year.